American Lithium
Home > Boards > Free Zone > Health and Sciences > Biotech Values

The SNTA trial is not blinded. The company

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
acgood Member Profile
 
Followed By 21
Posts 1,105
Boards Moderated 0
Alias Born 05/12/07
160x600 placeholder
acgood   Thursday, 09/06/12 11:27:04 PM
Re: iwfal post# 148299
Post # of 223688 
The SNTA trial is not blinded. The company sure had the data in hand for weeks last time as they talked the stock from 4 to 8 w/ wall street analysts in June. No reason to believe anything different is happening this time.

Two key notes for me from Stifel
- final PFS data for phase 3 already pushed back from 1h2014 to 2014 (and didn't reiterate 2014 NDA)
- didn't show/discuss the subgroup data - are they reversing and considering phase 3 in all adeno? mentioned OS benefit in all adeno specifically this time

Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist